Quick Takeaways
- venBio Global Strategic Fund, L.P. filed SCHEDULE 13D/A for ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO).
- Disclosed ownership: 10%.
- Date of event: 02 Feb 2026.
venBio Global Strategic Fund, L.P. - 02 Feb 2026 SCHEDULE 13D/A Report for ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO)
- Filing Manager
- venBio Global Strategic Fund, L.P.
- Reporting Manager
- GOODMAN COREY S
- Symbol
- ALXO
- Shares outstanding
- 131,635,490 shares
- Disclosed Ownership
- 13,163,549 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13D/A
- Filing time
- 04 Feb 2026, 21:03:01 UTC
- Date of event
- 02 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"venBio Global Strategic Fund, L.P. disclosed 10% ownership in ALX ONCOLOGY HOLDINGS INC Common Stock, par value $0.001 per share (ALXO) on 02 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 04 Feb 2026, 21:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (8)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| venBio Global Strategic Fund, L.P. | 3.4% | 4,431,600 | 0 | 4,431,600 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partners | 0001504130 |
| venBio Global Strategic Fund II L.P. | 6.4% | 8,453,038 | 0 | 8,453,038 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partners | 0001634632 |
| venBio Global Strategic GP, L.P. | 3.4% | 4,431,600 | 0 | 4,431,600 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner | 0001770834 |
| venBio Global Strategic GP II, L.P. | 6.4% | 8,453,038 | 0 | 8,453,038 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors of the General Partner | 0001729409 |
| venBio Global Strategic GP, Ltd. | 3.4% | 4,431,600 | 0 | 4,431,600 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors | 0001770835 |
| venBio Global Strategic GP II, Ltd. | 6.4% | 8,453,038 | 0 | 8,453,038 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Corey Goodman and Robert Adelman, Directors | 0001729408 |
| Adelman Robert J | 9.9% | 12,984,044 | 99,406 | 12,884,638 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact | 0001329161 |
| GOODMAN COREY S | 10% | 13,163,549 | 111,541 | 13,052,008 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact | 0001278411 |